No. | API Product | CAS No | DMF/CEP | Standard | Indication |
1 | Benazepril HCl 鹽酸貝那普利 | 86541-74-4 | NMPA DMF: Y20190002852 DMF: 033744 CEP:2015-322 CDSCO RC/BD-002644 | USP/EP/Ch.P. | Cardiovascular |
2 | Tirofiban HCl 鹽酸替羅非班 | 150915-40-5 | NMPA DMF: Y20190006974 DMF: 032701 EU/ASMF/00701 | In-house | Cardiovascular |
3 | Dronedarone HCl 鹽酸決奈達(dá)隆 | 141625-93-6 | NMPA DMF：Y20220000297 DMF: 037247 CEP: 2022-277 | USP/EP/Ch.P. | Cardiovascular |
4 | Eribulin Mesylate 甲磺酸艾立布林 | 441045-17-6 | DMF:035523 EU/ASMF/00569 | JP | Anti-Cancer |
5 | Ibrutinib(Form A&C) 伊布替尼 | 936563-96-1 | NMPA DMF: Y20230000804 DMF:038919 DMF:031917 | In-house | Anti-Cancer |
6 | Alogliptin Benzoate 苯甲酸阿格列汀 | 850649-62-6 | NMPA DMF: Y20230001355 DMF:039984 | In-house | Diabetes |
7 | Fosaprepitant Dimeglumine 福沙匹坦雙葡甲胺 | 265121-04-8 | NMPA DMF: Y20200001493 DMF:035766 JP MF:304MF10040 | In-house | Anti-Cancer |
8 | Aprepitant 阿瑞匹坦 | 170729-80-3 | NMPA DMF: Y20200000221 DMF:033175 CEP:2019-117 JP MF:230MF10074 | USP/EP | Anti-Cancer |
9 | Dapagliflozin 達(dá)格列凈 | 960404-48-2 | NMPA DMF: Y20220000848 | In-house | Diabetes |
10 | Entecavir 恩替卡韋 | 209216-23-9 | NMPA DMF: Y20170000425 DMF:033104 CEP:2018-006 | EP/USP | Anti-Virus |
11 | Gefitinib 吉非替尼 | 184475-35-2 | NMPA DMF: Y20200001369 CEP: 2022-291 | EP | Anti-Cancer |
12 | Linagliptin 利格列汀 | 668270-12-0 | DMF:031294 | In-house | Diabetes |
13 | Fasudil HCl 鹽酸法舒地爾 | 105628-07-7 | NMPA DMF: Y20220000495 JP MF:231MF10048 | Ch.P./JP | Cardiovascular |
14 | Flurbiprofen Axetil 氟比洛芬酯 | 91503-79-6 | NMPA DMF: Y20220000095 | In-house | Analgesic |
No. | API Product | CAS No | DMF/CEP | Standard | Indication |
15 | Difelikefalin Acetate 醋酸地非法林 | 1024829-44-4 | Validated | In-house | Antipruritic |
16 | Linaclotide 利那洛肽 | 851199-59-2 | In progress | In-house | IBS-C |
17 | Tirzepatide 替爾泊肽 | 2023788-19-2 | In progress | In-house | Diabetes |
18 | Etelcalcetide HCl 鹽酸依特卡肽 | 1334237-71-6 | In progress | In-house | SHPT |
19 | Semaglutide 司美格魯肽 | 910463-68-2 | In progress | In-house | Diabetes |
No. | API Product | CAS No | DMF/CEP | Standard | Indication |
20 | Trabectedin 曲貝替定 | 114899-77-3 | In progress | In-house | Anti-Cancer |
21 | Lurbinectedin 蘆比替定 | 497871-47-3 | DMF:037624 | In-house | Anti-Cancer |
22 | Baricitinib 巴瑞替尼 | 1187594-09-7 | DMF:036732 | In-house | Rheumatoid Arthritis |
23 | Carfilzomib 卡非佐米 | 868540-17-4 | In progress | In-house | Anti-Cancer |
24 | Pralsetinib 普拉替尼 | 2097132-94-8 | In progress | In-house | Anti-Cancer |
25 | Exatecan Mesylate 甲磺酸依喜替康 | 169869-90-3 | In progress | In-house | Anti-Cancer |
26 | Landiolol HCl 鹽酸蘭地洛爾 | 144481-98-1 | In progress | In-house | Cardiovascular |
27 | Pentoxifylline 己酮可可堿 | 6493-05-6 | In progress | In-house | Cardiovascular |
28 | Ozanimod HCl 鹽酸奧扎莫德 | 1618636-37-5 | In progress | In-house | Multiple Sclerosis |
29 | Enoxaparin Sodium 依諾肝素鈉 | 679809-58-6 | In progress | In-house | Cardiovascular |
30 | Dalteparin Sodium 達(dá)肝素鈉 | 9041-08-1 | In progress | In-house | Cardiovascular |
31 | Nadroparin Calcium 那屈肝素鈣 | 37270-89-6 | In progress | In-house | Cardiovascular |
32 | Parnaparin Sodium 帕肝素鈉 | 9041-08-1 | In progress | In-house | Cardiovascular |
33 | Reviparin sodium 瑞肝素鈉 | 9005-49-6 | In progress | In-house | Cardiovascular |
34 | Bemiparin Sodium 貝米肝素鈉 | 9041-08-1 | In progress | In-house | Cardiovascular |
35 | Fondaparinux Sodium 磺達(dá)肝癸鈉 | 114870-03-0 | DMF:037499 | In-house | Cardiovascular |
電話
0513-81292228
郵箱
sales@wisdompharma.com
地址
中國江蘇省南通市海門區(qū)三廠街道青化路18號(郵編:226123)
4009968186
tl_liu@wisdompharma.com
yc_han@wisdompharma.com
